Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: Reciprocal effect on enzymatic properties

Free Radical Research

Volumn 49, Issue 6, 2015, Pages 800-811

  Sokolov, Alexey Victorovich ^a,b,c   Kostevich, V A ^a,b   Zakharova, E T ^a   Samygina, V R ^d   Panasenko, O M ^b,e   Vasilyev, V B ^a,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d SHUBNIKOV INSTITUTE OF CRYSTALLOGRAPHY   (Russian Federation)

^e PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Ceruloplasmin; Eosinophil peroxidase; Halogenating activity; Myeloperoxidase; Protein protein interaction

Indexed keywords

2,2' AZINO BIS(3 ETHYLBENZTHIAZOLINE 6 SULFONATE); 4 CHLORO 1 NAPHTOL, 3,3 ,5,5 ' TETRAMETHYLBENZIDINE; BROMIDE; CERULOPLASMIN; DIANISIDINE; EOSINOPHIL PEROXIDASE; GUAIACOL; MYELOPEROXIDASE; PEROXIDASE; PHENYLENEDIAMINE; THIOCYANATE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PROTEIN BINDING;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING SITE; CHLORINATION; COMPARATIVE STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GEL ELECTROPHORESIS; GEL FILTRATION; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; NORMAL HUMAN; OXIDATION; PROTEIN DEGRADATION; PROTEIN PURIFICATION; SOLID PHASE SYNTHESIS; STATIC ELECTRICITY; STOICHIOMETRY; STRUCTURAL HOMOLOGY; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; HALOGENATION; IMMUNOLOGY; KINETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CERULOPLASMIN; ENZYME INHIBITORS; EOSINOPHIL PEROXIDASE; HALOGENATION; HUMANS; KINETICS; PEROXIDASE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84931272704     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2015.1005615     Document Type: Article

References (49)

1. Panasenko OM, Gorudko IV, Sokolov AV. Hypochlorous acid as a precursor of free radicals in living systems. Biochemistry (Mosc) 2013;78:1466-1489.
2. Sakamaki K, Tomonaga M, Tsukui K, Nagata S. Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. J Biol Chem 1989;264:16828-16836.
3. Furtmüller PG, Burner U, Obinger C. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. Biochemistry 1998;37:17923-17930.
4. Furtmüller PG, Jantschko W, Zederbauer M, Jakopitsch C, Arnhold J, Obinger C. Kinetics of interconversion of redox intermediates of lactoperoxidase, eosinophil peroxidase and myeloperoxidase. Jpn J Infect Dis 2004;57:S30-S31.
5. Arnhold J, Furtmüller PG, Regelsberger G, Obinger C. Redox properties of the couple compound I/native enzyme of myeloperoxidase and eosinophil peroxidase. Eur J Biochem 2001;268:5142-5148.
6. Hawkins CL, Davies MJ. The role of reactive N-bromo species and radical intermediates in hypobromous acid-induced protein oxidation. Free Radic Biol Med 2005;39:900-912.
7. Segelmark M, Persson B, Hellmark T, Wieslander J. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 1997;108:167-174.
8. Gitlin JD. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 1988;263:6281-6287.
9. Osaki S. Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). J Biol Chem 1966;241:5053-5059.
10. Stoj C, Kosman DJ. Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: implication for function. FEBS Lett 2003;554:422-426.
11. Vasil'ev VB, Kachurin AM, Soroka NV. Dismutation of superoxide radicals by ceruloplasmin-details of the mechanism. Biokhimiia 1988;53:2051-2058.
12. Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, Annavajjhala V, et al. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol 2006;2:486-493.
13. Kim IG, Park SY. Requirement of intact human ceruloplasmin for the glutathione-linked peroxidase activity. FEBS Lett 1998;437:293-296.
14. Sokolov AV, Ageeva KV, Pulina MO, Tcherkalina OS, Samygina VR, Vlasova II, et al. Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic Res 2008;42:989-998.
15. Panasenko OM, Chekanov AV, Vlasova II, Sokolov AV, Ageeva KV, Pulina MO, et al. A study of the effect of ceruloplasmin and lactoferrin on the chlorination activity of leukocytic myeloperoxidase using the chemiluminescence method. Biofizika 2008;53:573-581.
16. Sokolov AV, Golenkina EA, Kostevich VA, Vasilyev VB, Sud'ina GF. Interaction of ceruloplasmin and 5-lipoxygenase. Biochemistry (Mosc) 2010;75:1464-1469.
17. Samygina VR, Sokolov AV, Bourenkov G, Petoukhov MV, Pulina MO, Zakharova ET, et al. Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins. PLoS One 2013;8:e67145.
18. Sokolov AV, Zakahrova ET, Kostevich VA, Samygina VR, Vasilyev VB. Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes. Biometals 2014;27:815-828.
19. Sokolov AV, Kostevich VA, Runova OL, Gorudko IV, Vasilyev VB, Cherenkevich SN, Panasenko OM. Proatherogenic modification of LDL by surface-bound myeloperoxidase. Chem Phys Lipids 2014;180:72-80.
20. Sokolov AV, Zakharova ET, ShavlovskiѤ MM, Vasil'ev VB. Isolation of stable human ceruloplasmin and its interaction with salmon protamine. Bioorg Khim 2005;31:269-279.
21. Sokolov AV, Kostevich VA, Romanico DN, Zakharova ET, Vasilyev VB. Two-stage method for purification of ceruloplasmin based on its interaction with neomycin. Biochemistry (Mosc) 2012;77:631-638.
22. Noyer M, Dwulet FE, Hao YL, Putnam FW. Purification and characterization of undegraded human ceruloplasmin. Anal Biochem 1980;102:450-458.
23. Bolscher BG, Plat H, Wever R. Some properties of human eosinophil peroxidase, a comparison with other peroxidases. Biochim Biophys Acta 1984;784:177-186.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-686.
25. Davis BJ. Disc electrophoresis. II. Method and application to human serum proteins. Ann N Y Acad Sci 1964;121:404-427.
26. Owen CA, Smith H. Detection of ceruloplasmin after zone electrophoresis. Clin Chim Acta 1961;6:441-444.
27. Sokolov AV, Ageeva KV, Cherkalina OS, Pulina MO, Zakharova ET, Prozorovskii VN, et al. Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin. Chem Phys Lipids 2010;163:347-355.
28. Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem 2003;312:224-227.
29. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008;9:40
30. Weiler JM, Edens RE, Gleich GJ. Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway. J Immunol 1992;149:643-648.
31. Sokolov AV, Pulina MO, Ageeva KV, Ayrapetov MI, Berlov MN, Volgin GN, etal. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase. Biochemistry (Mosc) 2007;72:409-415.
32. Sokolov AV, Ageeva KV, Kostevich VA, Berlov MN, Runova OL, Zakharova ET, Vasilyev VB. Study of interaction of ceruloplasmin with serprocidins. Biochemistry (Mosc) 2010;75:1361-1367.
33. Furtmüller PG, Zederbauer M, Jantschko W, Helm J, Bogner M, Jakopitsch C, Obinger C. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 2006;445:199-213.
34. van Dalen CJ, Kettle AJ. Substrates and products of eosinophil peroxidase. Biochem J 2001;358:233-239.
35. van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 1997;327:487-492.
36. Chandler JD, Day BJ. Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. Biochem Pharmacol 2012;84:1381-1387.
37. Sokolov AV, Ageeva KV, Pulina MO, Zakharova ET, Vasilyev VB. Effect of lactoferrin on oxidative features of ceruloplasmin. Biometals 2009;22:521-529.
38. Chapman AL, Mocatta TJ, Shiva S, Seidel A, Chen B, Khalilova I, et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem 2013;288:6465-6477.
39. De Filippis V, Vassiliev VB, Beltramini M, Fontana A, Salvato B, Gaitskhoki VS. Evidence for the molten globule state of human apo-ceruloplasmin. Biochim Biophys Acta 1996;1297:119-123.
40. Vachette P, Dainese E, Vasyliev VB, Di Muro P, Beltramini M, Svergun DI, De Filippis V, Salvato B. A key structural role for active site type 3 copper ions in human ceruloplasmin. J Biol Chem 2002;277:40823-40831.
41. Saude EJ, Lacy P, Musat-Marcu S, Mayes DC, Bagu J, Man SF, Sykes BD, Moqbel R. NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magn Reson Med 2004;52:807-814.
42. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001;166:5763-5772.
43. Higashi N, Mita H, Taniguchi M, Turikisawa N, Higashi A, Ozawa Y, et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol 2004;114:1353-1358.
44. Pattison DI, Davies MJ. Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry 2004;43:4799-4809.
45. Panasenko OM, Vakhrusheva T, Tretyakov V, Spalteholz H, Arnhold J. Influence of chloride on modification of unsaturated phosphatidylcholines by the myeloperoxidase/hydrogen peroxide/bromide system. Chem Phys Lipids 2007;149:40-51.
46. Senthilmohan R, Kettle AJ. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch Biochem Biophys 2006;445:235-244.
47. Squitti R, Quattrocchi CC, Salustri C, Rossini PM. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease. Prion 2008;2:23-27.
48. Sokolov AV, Pulina MO, Ageeva KV, Tcherkalina OS, Zakharova ET, Vasilyev VB. Identification of complexes formed by ceruloplasmin with matrix metalloproteinases 2 and 12. Biochemistry (Mosc) 2009;74:1388-1392.
49. Sokolov AV, Pulina MO, Ageeva KV, Runova OL, Zakharova ET, Vasil'ev VB. Identification of leukocyte cationic proteins that interact with ceruloplasmin. Biochemistry (Mosc) 2007;72:872-877.